Results of phase 2 randomized multi-center study to evaluate the safety and efficacy of infusion of memory T cells as adoptive therapy in severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) pneumonia and/or lymphopenia (RELEASE NCT04578210)

  1. Ferreras, C.
  2. Hernández-Blanco, C.
  3. Martín-Quirós, A.
  4. Al-Akioui-Sanz, K.
  5. Mora-Rillo, M.
  6. Ibáñez, F.
  7. Díaz-Almirón, M.
  8. Cano-Ochando, J.
  9. Lozano-Ojalvo, D.
  10. Jiménez-González, M.
  11. Goterris, R.
  12. Sánchez-Zapardiel, E.
  13. de Paz, R.
  14. Guerra-García, P.
  15. Queiruga-Parada, J.
  16. Molina, P.
  17. Briones, M.L.
  18. Ruz-Caracuel, B.
  19. Borobia, A.M.
  20. Carcas, A.J.
  21. Planelles, D.
  22. Vicario, J.L.
  23. Moreno, M.Á.
  24. Balas, A.
  25. Llano, M.
  26. Llorente, A.
  27. del Balzo, Á.
  28. Cañada, C.
  29. García, M.Á.
  30. Calvin, M.E.
  31. Arenas, I.
  32. Pérez de Diego, R.
  33. Eguizábal, C.
  34. Soria, B.
  35. Solano, C.
  36. Pérez-Martínez, A.
  37. Show all authors +
Journal:
Cytotherapy

ISSN: 1477-2566 1465-3249

Year of publication: 2024

Volume: 26

Issue: 1

Pages: 25-35

Type: Article

DOI: 10.1016/J.JCYT.2023.10.002 GOOGLE SCHOLAR